The series on “How to Detect and Treat NSCLC Patients with Oncogenic Fusions” was edited by Drs Fabrizio Tabbò (University of Turin, Italy), Umberto Malapelle (University of Naples Federico II, Italy), Maria Lucia Reale (University of Turin, Italy), Angela Listì (University of Turin, Italy).
Review Article
Review: biological implications of oncogenic rearrangements in non-small cell lung cancer
The role of digital and integrative pathology for the detection of translocations: a narrative review
ALK fusions turn sixteen in lung cancer: a review on their biology, detection and therapy
Current state of the art on the diagnosis and the role of target therapy for treatment of ROS1-rearranged non-small cell lung cancer: a narrative review
NRG1 fusions in non-small cell lung cancer: a narrative review on biology, detection and therapy
Genetic and non-genetic resistance mechanisms in non-small cell lung cancer harboring (non-ALK) oncogenic fusions
NTRK1/2/3: biology, detection and therapy
Disclosure:
The series “How to Detect and Treat NSCLC Patients with Oncogenic Fusions” was commissioned by the editorial office, Precision Cancer Medicine without any sponsorship or funding. Drs Fabrizio Tabbò, Umberto Malapelle, Maria Lucia Reale, and Angela Listì served as the unpaid Guest Editors for the series.